Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Adolescent Idiopathic Scoliosis (AIS)
Last updated on April 2022Recruitment
- Recruitment Status
- Terminated
- Estimated Enrollment
- 40
Inclusion Criteria
- Risser sign of 1 to 5
- Flexible major curve, correction to below 30° at lateral bending.
- 11≤ Adolescents < 20 years old
- ...
- Risser sign of 1 to 5
- Flexible major curve, correction to below 30° at lateral bending.
- 11≤ Adolescents < 20 years old
- Minimum of 35 degrees Cobb angle, confirmed by X-ray. Lenke type 1 or 5
- Subject has no known hypersensitivity and allergies to Titanium
- Patient undergoing treatment of AIS by the MID-C system in daily practice
- Subject has good general health as determined by physician.
- Appropriate candidate for posterior surgical approach as determined by surgeon
- Subject's guardian willing to sign a written Informed Consent Form (ICF)
Exclusion Criteria
- Mentally compromised as determined by the physician
- AIS which is not defined as Lenke type 1 or 5
- Previous spine surgery.
- ...
- Mentally compromised as determined by the physician
- AIS which is not defined as Lenke type 1 or 5
- Previous spine surgery.
- Systemic disease that would affect the subject's welfare or overall outcome of the study as determined by the physician.
- Cobb angle over 60 degrees
- Other non-idiopathic scoliosis.
- Known active systemic disease, such as AIDS, HIV, or active infection
- Known allergy to any component of the device.
Summary
- Conditions
- Adolescent Idiopathic Scoliosis (AIS)
- Design
- Observational Model: Cohort
- Time Perspective: Prospective
Participation Requirements
- Age
- Between 11 years and 20 years
- Gender
- Both males and females
Description
The study is designed as a European, observational study with a 12-month follow-up period. Consecutive patients undergoing treatment of AIS by the MID-C system in daily practice will be included during a 6-month enrollment period.
The study is designed as a European, observational study with a 12-month follow-up period. Consecutive patients undergoing treatment of AIS by the MID-C system in daily practice will be included during a 6-month enrollment period.
Inclusion Criteria
- Risser sign of 1 to 5
- Flexible major curve, correction to below 30° at lateral bending.
- 11≤ Adolescents < 20 years old
- ...
- Risser sign of 1 to 5
- Flexible major curve, correction to below 30° at lateral bending.
- 11≤ Adolescents < 20 years old
- Minimum of 35 degrees Cobb angle, confirmed by X-ray. Lenke type 1 or 5
- Subject has no known hypersensitivity and allergies to Titanium
- Patient undergoing treatment of AIS by the MID-C system in daily practice
- Subject has good general health as determined by physician.
- Appropriate candidate for posterior surgical approach as determined by surgeon
- Subject's guardian willing to sign a written Informed Consent Form (ICF)
Exclusion Criteria
- Mentally compromised as determined by the physician
- AIS which is not defined as Lenke type 1 or 5
- Previous spine surgery.
- ...
- Mentally compromised as determined by the physician
- AIS which is not defined as Lenke type 1 or 5
- Previous spine surgery.
- Systemic disease that would affect the subject's welfare or overall outcome of the study as determined by the physician.
- Cobb angle over 60 degrees
- Other non-idiopathic scoliosis.
- Known active systemic disease, such as AIDS, HIV, or active infection
- Known allergy to any component of the device.
Tracking Information
- NCT #
- NCT02200302
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: JEAN-CHARLES LE HUEC, PD Dr. med. Unité d'Orthopédie-traumatologie, Rachis II
- JEAN-CHARLES LE HUEC, PD Dr. med. Unité d'Orthopédie-traumatologie, Rachis II